Integer Holdings (ITGR) Net Cash Flow Growth (3y) (2013 - 2026)
Integer Holdings (ITGR) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | -48.90% |
| 10 | Integer Holdings | 3.42 Bn | 3.41 Bn | 109.60 Mn | -38.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -38.24% |
| Dec 31, 2025 | -104.77% |
| Sep 26, 2025 | 174.09% |
| Jun 27, 2025 | -50.91% |
| Mar 28, 2025 | -60.38% |
| Dec 31, 2024 | 49.01% |
| Sep 27, 2024 | 33.64% |
| Jun 28, 2024 | -81.55% |
| Mar 29, 2024 | 42.32% |
| Dec 31, 2023 | 47.22% |
| Sep 29, 2023 | 61.06% |
| Jun 30, 2023 | -26.25% |
| Mar 31, 2023 | -15.21% |
| Dec 31, 2022 | 133.29% |
| Sep 30, 2022 | -22.22% |
| Jul 1, 2022 | -45.35% |
| Apr 1, 2022 | 36.49% |
| Dec 31, 2021 | -84.25% |
| Oct 1, 2021 | -53.51% |
| Jul 2, 2021 | 29.59% |